Hjem › Hode- og halskreft › Illinois › Chicago
Kliniske studier for Hode- og halskreft i Chicago, IL
10 studier for Hode- og halskreft søker deltakere på steder i og rundt Chicago (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
RekruttererFase 2/3
- Captain James A Lovell Federal Health Care Center-VA North Chicago (Site # 133), Chicago
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekruttererFase 2
- University of Illinois Cancer Center, Chicago
A Study Comparing Two Immunotherapy Options for Human Papillomavirus Positive HPV-Positive Head and Neck Cancer After Treatment
RekruttererFase 2
- The University of Chicago, Chicago
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RekruttererFase 1/2
- University of Chicago, Chicago
A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer
RekruttererFase 2
- University of Chicago Comprehensive Cancer Center, Chicago
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
RekruttererFase 1
- The University of Chicago, Chicago
Response-Adaptive Treatment in Untreated Locoregional HPV-Negative Head and Neck Cancer
RekruttererFase 2
- The University of Chicago, Chicago
Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC
RekruttererFase 1
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Chicago
Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer
RekruttererFase 1/2
- University of Illinois at Chicago, Chicago
Hode- og halskreft-studier i andre byer
- Houston, TX30 studier
- Boston, MA22 studier
- New York City, NY21 studier
- Nashville, TN21 studier
- St. Louis, MO15 studier
- Dallas, TX12 studier
- Pittsburgh, PA11 studier
- Los Angeles, CA10 studier
- San Antonio, TX10 studier
- Baltimore, MD10 studier
- Washington, DC10 studier
- Durham, NC10 studier
Andre studier i Chicago
- Ikke-småcellet lungekreft61 studier
- Brystkreft59 studier
- Kreft (alle typer)51 studier
- Metastatisk kreft45 studier
- Prostatakreft45 studier
- Lungekreft41 studier
- Fedme41 studier
- Eggstokkreft36 studier
- Kolorektal kreft34 studier
- Slag34 studier
- Hjertesvikt31 studier
- Overvekt29 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.